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ABSTRACT
The aim of the study was to model hepatic steatosis as a manifestation of metabolic
syndrome in male Wistar rats after an 8-week administration of 15% fructose.
Ultrasonographic evaluation of the experimental group showed evidence of non-alcoholic
fatty liver disease (NAFLD). Alanine aminotransferase (ALT), aspartate aminotransferase
(AST) and uric acid were significantly elevated in sera from the treated rats. Histological
examination found development of hepatic steatosis in rats of the fructose group
compared with controls. The current study showed the risk associated with fructose
overconsumption in food and beverages for the development of metabolic syndrome and
related fatty liver disease, gout, type 2 diabetes, arterial hypertension and other disorders.
INTRODUCTION
Successful treatment of chronic viral hepatitis and the pandemic of obesity and type
2 diabetes lead to the current unfortunate result that NAFLD became a leading cause for
chronic liver disorder in humans (Vanni et al., 2010; Weston et al., 2005). As a hepatic
manifestation of metabolic syndrome liver steatosis leads to non-alcoholic steatohepatitis
(NASH) with or without cirrhosis and hepatocellular carcinoma (Farrell and Larter, 2006).
Overconsumption of fructose (HFCS - high fructose corn syrup, in Bulgaria used
under the name glucose-fructose syrup) instead of sucrose in recent decades also
contributed for the increased incidence of metabolic syndrome and type 2 diabetes. The
abuse of this sweetener through consumption of highly processed foods and beverages
causes inflammation in the liver resulting in development of NAFLD (Bray et al., 2004;
Bocarsly et al., 2010; Tappy and Le, 2010; Stanhope et al., 2008; Stanhope et al., 2009).
NAFLD pathogenesis was initially proposed by Day and James (1998). Insulin
resistance causes lipid accumulation in hepatocytes and leads to development of fatty
liver. Oxidative stress, lipid oxidation, and chronic inflammation result in NASH. Fatty liver
develops when de novo synthesis exceeds the oxidation and re-secretion of triglycerides
through several mechanisms (Fujita et al., 2009; Musso et al., 2009; Schwarz et al., 2003):
 Increased free fatty acids (FFA) supply due to increased lipolysis from both
visceral/subcutaneous adipose tissue as a result of IR;
 Increased intake of dietary fat sources of FFA;
 Increased de novo lipogenesis;
 Alteration in the synthesis or secretion of lipoproteins and reduction in mitochondrial
fatty acids (FA) β-oxidation.
There is evidence that the rate of de novo lipid synthesis is elevated in livers of patients
with NAFLD, compared with healthy subjects (Schadinger et al., 2005). A shift from FA
oxidation to de novo lipid synthesis is mediated by an increased activity of the transcription
factors PPAR gamma-2 (Schadinger et al., 2005), ChREBP and SREBP-1c (Shimomura
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et al., 1999), all of which are positive modulators of hepatic triglycerides contents by
targeting genes coding for key reactions in lipid synthesis.
The aim of this study was to model hepatic steatosis as a manifestation of metabolic
syndrome in male Wistar rats through an 8-week administration of 15% fructose and to
track ultrasound, biochemical and histological changes.
MATERIALS AND METHODS
Fourteen male Wistar rats initially weighing circa 250 g were studied for 8 weeks.
The control group C (n = 7) received drinking water and standard rodent chow. The
experimental (fructose) group F (n = 7) received solution of 15% fructose in drinking water
and the same food ad libitum. The rats were kept in the accredited Vivarium at the Medical
Faculty, Trakia University at 25±1°C with a photoperiod light/dark of 12/12 hours and free
access to water and food. The containers with water and 15% fructose solution were
supplemented every two days, once a week the amount consumed by both groups was
calculated and the average intake of fructose in g/100 g body weight per day for the
experimental group was determined. All animals’ weight was measured at the start of the
experiment and at the end of each week. At the beginning and the end of the experimental
period the length of the rats (distance nose-anus) was measured and the Lee Index was
calculated. Lee Index in rats is equivalent to the body mass index (BMI) in humans.
Lee Index= 3√body weight (g)/length (cm) × 1000
The experiment was conducted in compliance with the requirements of national
legislation and the European Directive 2010/63/EU on the protection of animals used for
scientific purposes.
In sera from venous blood collected from the tail vein at the beginning and from the
abdominal aorta at the end of the experimental period glucose, lipid parameters
(triglycerides, total cholesterol, HDL and LDL cholesterol), and levels of uric acid, alanine
aminotransferase (ALT), aspartate aminotransferase (AST) and gamma-glutamyl
transpeptidase (GGT) were examined using an automatic analyzer Mindray BS300. The
results were analyzed by Student's t-test on Statsoft Statistica v.8.
During the seventh week ultrasound on the liver of animals was performed after
anesthesia with ketamine and xylazine. The study was conducted with ultrasound
equipment Diagnostic Ultrasound System (model DC-6V Shenzhen Mindray Bio-medical,
Electronics Co, Ltd, China).
At the end of the experiment the rats were euthanized with a lethal dose of the
same anesthetics. Depots of retroperitoneal, mesenteric (visceral) and subcutaneous
adipose tissue of the back were removed and measured in mg/100 g body weight. The
liver weight was measured and liver-to-body weight ratio in grams was calculated.
Histological samples from the livers stained with haematoxylin-eosin were prepared and
observed under a microscope Leica DM 2500 Microsystems at x200 magnification.
RESULTS AND DISCUSSIONS
Figure 1 shows the change in body weight of the control and experimental
(fructose-fed) group of rats. There was no statistically significant difference (p = 0.0838)
between body weight of the two groups at the end of the 8-week period.  But still in terms
of mean body weight there was an increase in the fructose group compared with controls.
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Figure 1. Mean body weight (g) of fructose-fed and control rats
Bocarsly et al. (2010), Martines et al. (2010), and Lindqvist et al. (2008) found
similar changes in body weight and liver weight/body weight in fructose-fed rats. According
to Теff et al. (2004) a cause for these changes could be the reduction of plasma insulin
and leptin and the elevation of ghrelin due to fructose consumption thus increasing long-
term caloric intake. No change in circulating ghrelin was observed after food intake in
obese people, whereas in lean individuals it decreased by 40% half an hour after a meal.
Therefore the continuous postprandial ghrelin secretion in obese individuals leads to
increased food intake.
Table 1 shows mean levels of some biochemical and morphological parameters of
the fructose-fed group of rats compared with controls. Significant difference was found in
the mesenteric fat depot weight (mg/100g bw). No differences were observed between the
two groups in retroperitoneal and subcutaneous posterior fat depot weight. An increase in
visceral fat depots in fructose-fed rats found Stanhope et al. (2008).
The Lee index in fructose rats compared with controls showed no significant
changes (p = 0.0503). This was probably due to the greater length of the rats from the
fructose group at the end of the experiment, as suggested by other researchers (Cinti,
2005). Liver weight/body weight ratio of the fructose group was significantly higher than
the control group.
Table 1.
Biochemical and morphological parameters (mean values and SD) of fructose-fed
and control rats
Group
Parameter
Control (C) Fructose (F)
Mean SD Mean SD
Serum glucose (mM) 5.43 0.75 9.79* 2.48
Serum total cholesterol (mM) 1.75 0.12 2.1 0.42
Serum HDL-cholesterol (mM) 0.5 0.08 0.39* 0.05
Serum LDL-cholesterol (mM) 0.73 0.07 0.85* 0.04
Serum TAG (mM) 0.72 0.24 1.91* 0.87
Uric acid (μM) 17.43 5.26 31.86* 12.97
AST (U/L) 117.57 19.18 162.86* 34.28
ALT (U/L) 41.14 12.21 60.57* 15.25
GGT (U/L) 1.86 0.48 1.61 0.39
250
300
350
400
Week 0 Week 1 Week 2 Week 3 Week 4  Week 5 Week 6 Week 7 Week 8
Fructose
Control
Analele Universităţii din Craiova, seria Agricultură – Montanologie – Cadastru (Annals of the University of Craiova - Agriculture,
Montanology, Cadastre Series) Vol. XLV 2015
243
Retroperitoneal fat depot weight (mg/100 g bw) 815.9 240.15 1137.8 332.24
Mesenteric fat depot weight (mg/100 g bw) 1075.64 254.42 1763.45* 709.98
Subcutaneous posterior fat depot weight (mg/100 g bw) 124.63 53.13 154.0 61.47
Liver weight/Body weight (g/g) 0.036 0.03 0.041* 0.003
Lee Index 288.92 8.69 298.8 8.3
* significant difference vs. controls (p < 0.05)
Serum glucose, triglycerides, and LDL cholesterol of the fructose-fed rats were also
significantly elevated compared with the control group, while HDL cholesterol was
significantly lower. Such changes in the lipid profile at 4-week administration of 60%
fructose in 3-month-old male Wistar rats established De Moura et al. (2009). Increased de
novo lipogenesis in the liver leads to enlargement of visceral fat tissue and worsened
plasma lipid profile, hence increased atherogenic risk and lipotoxicity.
Table 1 shows that significant elevation compared with the control group was found
also for uric acid and liver transaminases (AST, ALT), but not for GGT. Increased uric acid
is considered a minor criterion in the definition of metabolic syndrome and explains the
higher incidence of gout, renal calculosis and type 2 diabetes in those patients due to the
creation of pre-receptor insulin resistance. Uric acid inhibits the synthesis of the
vasodilator nitric oxide and of the enzyme nitric oxide synthase, decreases blood flow and
is considered one of the causes for fructose-induced hypertension. According to Douard
and Ferraris (2013) expression of the glucose transporter protein (GLUT 5), increased
intestinal salt reabsorption and reduced renal salt excretion all contribute to this type of
hypertension. Brown et al. (2008) reported significantly increased blood pressure, heart
rate, and cardiac output in healthy young volunteers after ingestion of fructose-sweetened
drink.
Ultrasonographic and histological examination confirmed the development of fatty
liver in animals from the fructose group. Ultrasound images of transverse section of the
liver of fructose-fed rats showed hyperechogenic liver with rough granular structure -
Figure 2(A). In control rats the ultrasound image was normal with clearly defined
gallbladder - Figure 2(B).
(A)
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(B)
Figure 2. Ultrasound image of the liver of laboratory rats (transverse section).
A: Fructose group B: Control group
Figure 3 shows samples of histological studies using haematoxylin eosin staining of
liver tissue. In livers of fructose-fed rats with light vacuoles (emptied oil drops) in the
cytoplasm of hepatocytes: (A) and (B), and normal hepatocytes with part of the vena
centralis of a control rat (C). Similar histological changes found Martines et al. (2010).
Their results indicated the presence of a greater amount of lipid clusters in the livers of rats
drinking 15% fructose solution.
(A)
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(B)
(C)
Figure 3. Histological samples of liver tissue of laboratory rats
(haematoxylin eosin staining at x200 magnification).
A and B: Fructose group C: Control group
CONCLUSIONS
The development of metabolic syndrome and hepatic steatosis in experimental rats
after 8-week consumption of 15% fructose solution demonstrates the need to limit the
intake of this sweetener as an opportunity to reduce the current global epidemic of obesity,
type 2 diabetes, nonalcoholic liver steatosis, gout and other chronic diseases.
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